Carsten Spannhuth, MD, eMBA is a highly experienced individual in the medical and biopharmaceutical field. Currently holding multiple key positions in various companies, Carsten is a driving force in the development of treatments for neurodegenerative, neurodevelopmental, and CNS disorders. With a strong background in clinical development and global leadership, Carsten has played pivotal roles in the success of numerous clinical development programs and licensing initiatives. Spannhuth's expertise spans across different therapeutic areas, showcasing their versatility and proficiency in the industry.
2024 - present